Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical TrialConstantin‐Cristian Topriceanu, Carolyn Y. Ho, Anna Axelsson Raja et al.|Circulation Heart Failure|2025Cited by 3
Plasma Proteomics Reveals Dysregulated Pathways Across the Spectrum <i>LMNA</i> CardiomyopathyUsman A. Tahir, Neal K. Lakdawala, Carolyn Y. Ho et al.|Circulation Genomic and Precision Medicine|2025Cited by 1